PatentVest Report Highlights Muscle-Preservation Category as Emerging Opportunity for Obesity Therapeutics
A new report from PatentVest identifies muscle-preservation therapies as a growing category within obesity treatment. The analysis highlights 20 programs in development and suggests that these strategies could enhance long-term outcomes of GLP-1 treatments, potentially reshaping the sector through partnerships, acquisitions, and IP opportunities.
Topics: GLP-1 IP strategy muscle preservation myostatin inhibition obesity therapeutics